Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.

[1]  J. Sommer,et al.  Retention of Iodine and Expression of Biomarkers for Renal Damage in the Kidney After Application of Iodinated Contrast Media in Rats , 2009, Investigative radiology.

[2]  P. Delanaye,et al.  Formula-Based Estimates of the GFR: Equations Variable and Uncertain , 2008, Nephron Clinical Practice.

[3]  U. Schoepf,et al.  Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. , 2008, Radiology.

[4]  Bert Flemming,et al.  Viscosity of contrast media perturbs renal hemodynamics. , 2007, Journal of the American Society of Nephrology : JASN.

[5]  J. Newhouse,et al.  Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. , 2006, Radiology.

[6]  R. Mehran,et al.  Contrast-induced nephropathy: definition, epidemiology, and patients at risk. , 2006, Kidney international. Supplement.

[7]  R. Katzberg,et al.  Contrast-induced nephrotoxicity: clinical landscape. , 2006, Kidney international. Supplement.

[8]  D. Weishaupt,et al.  Persistent nephrogram after administration of an isoosmolar contrast medium. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  H. Yamazaki,et al.  Renal cortical retention on delayed CT and nephropathy following transcatheter arterial chemoembolisation. , 2001, The British journal of radiology.

[10]  M. Cova,et al.  Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. , 1998, The British journal of radiology.

[11]  T. Nose,et al.  Renal cortical retention on delayed CT after angiography and contrast associated nephropathy. , 1997, The British journal of radiology.

[12]  B. Grynne,et al.  Safety, tolerance, and pharmacokinetics of iodixanol injection, a nonionic, isosmolar, hexa-iodinated contrast agent. , 1996, Academic radiology.

[13]  R. Shifrin,et al.  The CT nephrogram: implications for evaluation of urinary tract disease. , 1995, Radiographics : a review publication of the Radiological Society of North America, Inc.

[14]  K. Golman,et al.  Renal Effects of Iodixanol in Experimental Animals , 1995, Acta radiologica. Supplementum.

[15]  J. Jakobsen.  Renal Effects of Iodixanol in Healthy Volunteers and Patients with Severe Renal Failure , 1995, Acta radiologica. Supplementum.

[16]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[17]  N. Powe,et al.  Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. , 1992, Radiology.

[18]  T. Haider,et al.  Human pharmacokinetics of iodixanol. , 1992, Investigative radiology.

[19]  J. Hald,et al.  Evaluation of renal function with delayed CT after injection of nonionic monomeric and dimeric contrast media in healthy volunteers. , 1992, Radiology.

[20]  M. Olson,et al.  Persistent CT nephrogram: significance in the diagnosis of contrast nephropathy. , 1989, Radiology.

[21]  R. Choplin,et al.  The abnormal nephrogram. , 1986, Radiographics : a review publication of the Radiological Society of North America, Inc.

[22]  M. Korobkin,et al.  Contrast-induced acute renal failure: persistent nephrogram as clue to early detection. , 1980, AJR. American journal of roentgenology.

[23]  K. Rootwelt,et al.  Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention. , 1996, Nephron.